Literature DB >> 8126133

Exclusion of growth hormone (GH)-releasing hormone gene mutations in familial isolated GH deficiency by linkage and single strand conformation analysis.

L A Pérez Jurado1, J A Phillips, U Francke.   

Abstract

The molecular basis and the locus responsible for most familial cases of isolated GH deficiency (IGHD) are still unknown. The GH-releasing hormone (GHRH) gene has been evaluated as a possible candidate in 23 unrelated families with IGHD, 14 of whom were classified as having autosomal recessive IGHD type IB and 9 of whom had autosomal dominant IGHD type II. Three highly polymorphic microsatellites (dinucleotide repeats), mapped close to GHRH on chromosome 20 by previous linkage studies, were analyzed as markers for the GHRH locus. All available family members were genotyped for D20S44 [no recombination with GHRH at a LOD (logarithm of the odds) score of 3.6]. Noninformative families were also genotyped for D20S45 and/or D20S54 (located at approximately 1 and 3 centiMorgan of genetic distance from GHRH, respectively). Twenty families were informative for linkage analysis with 1 or more of these markers. We found at least 1 obligate recombinant with discordance between phenotype and genotype in 19 of the 23 families (83%). There is only a very small chance (1-3% or less) that the discordances observed are due to recombination between the GHRH locus and the marker tested. Concordant segregation was seen in only 1 type IB family (4%). When probands from this and the 3 noninformative families were screened for sequence variants in the 5 exons of the GHRH gene by single strand conformation analysis, no abnormal patterns were observed. We conclude that mutations responsible for IGHD are not within or near the structural gene for GHRH on chromosome 20 in the 23 families studied. As linkage to the GH-1 gene has also been previously excluded in 65% of these families, mutations in a locus or loci unlinked to GH-1 and GHRH must be responsible for the majority of these IGHD families.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126133     DOI: 10.1210/jcem.78.3.8126133

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  Growth hormone and IGF-1.

Authors:  Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

2.  Molecular definition of the chromosome 7 deletion in Williams syndrome and parent-of-origin effects on growth.

Authors:  L A Pérez Jurado; R Peoples; P Kaplan; B C Hamel; U Francke
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

Review 3.  Growth hormone-releasing hormone receptor signaling in experimental ocular inflammation and neuroprotection.

Authors:  Ling-Ping Cen; Tsz Kin Ng; Wai Kit Chu; Chi Pui Pang
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

Review 4.  Genetics of isolated growth hormone deficiency.

Authors:  Primus E Mullis
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.